These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25011912)

  • 1. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
    Afzal O; Kumar S; Kumar R; Firoz A; Jaggi M; Bawa S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3986-96. PubMed ID: 25011912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.
    Jha V; Biagi M; Spinelli V; Di Stefano M; Macchia M; Minutolo F; Granchi C; Poli G; Tuccinardi T
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a new reversible MAGL inhibitor.
    Tuccinardi T; Granchi C; Rizzolio F; Caligiuri I; Battistello V; Toffoli G; Minutolo F; Macchia M; Martinelli A
    Bioorg Med Chem; 2014 Jul; 22(13):3285-91. PubMed ID: 24853323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.
    Xiong F; Ding X; Zhang H; Luo X; Chen K; Jiang H; Luo C; Xu H
    Bioorg Med Chem Lett; 2021 Jun; 41():127986. PubMed ID: 33766770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
    Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
    Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
    Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
    Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
    Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.
    Granchi C; Rizzolio F; Bordoni V; Caligiuri I; Manera C; Macchia M; Minutolo F; Martinelli A; Giordano A; Tuccinardi T
    J Enzyme Inhib Med Chem; 2016; 31(1):137-46. PubMed ID: 25669350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
    Granchi C; Lapillo M; Glasmacher S; Bononi G; Licari C; Poli G; El Boustani M; Caligiuri I; Rizzolio F; Gertsch J; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    J Med Chem; 2019 Feb; 62(4):1932-1958. PubMed ID: 30715876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.
    Szabo M; Agostino M; Malone DT; Yuriev E; Capuano B
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6782-7. PubMed ID: 21982493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
    Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase.
    Lauria S; Perrotta C; Casati S; Di Renzo I; Ottria R; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
    Bioorg Med Chem; 2018 May; 26(9):2561-2572. PubMed ID: 29678535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
    Morera L; Labar G; Ortar G; Lambert DM
    Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
    Poli G; Lapillo M; Jha V; Mouawad N; Caligiuri I; Macchia M; Minutolo F; Rizzolio F; Tuccinardi T; Granchi C
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):589-596. PubMed ID: 30696302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.
    Bononi G; Tonarini G; Poli G; Barravecchia I; Caligiuri I; Macchia M; Rizzolio F; Demontis GC; Minutolo F; Granchi C; Tuccinardi T
    Eur J Med Chem; 2021 Nov; 223():113679. PubMed ID: 34218085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.
    Kapanda CN; Masquelier J; Labar G; Muccioli GG; Poupaert JH; Lambert DM
    J Med Chem; 2012 Jun; 55(12):5774-83. PubMed ID: 22651858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
    Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.